Biotangents is a startup based in the United Kingdom, most recent round Series A, 2 tracked investors.
Biotangents is a company founded in 2018 headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Biotangents develops rapid, molecular diagnostic tests for infectious diseases in livestock, focusing initially on bovine viral diarrhea and mastitis. Their technology enables lab-quality results directly on farms or in veterinary clinics within under two hours.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.